Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Revenue 2018–2025
Black Diamond Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Black Diamond Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Black Diamond Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 70.0 M.
- Black Diamond Therapeutics, Inc. annual revenue for 2025 was 70.0 M.
- Black Diamond Therapeutics, Inc. annual revenue for 2024 was 0.
- Black Diamond Therapeutics, Inc. annual revenue for 2020 was 0.
- Black Diamond Therapeutics, Inc. annual revenue for 2019 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Black Diamond Therapeutics, Inc. Earnings — FAQ
Black Diamond Therapeutics, Inc. (BDTX) earnings over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDTX's earnings history?
The chart and table above show Black Diamond Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.